Peter Boyd's most recent trade in Aquestive Therapeutics Inc was a trade of 2,293 Common Stock done at an average price of $1.0 . Disclosure was reported to the exchange on Sept. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics Inc | Mr. Peter Boyd | Chief People Officer | 09 Sep 2026 | 2,293 | 284,024 (0%) | 0% | 1.0 | 2,201 | Common Stock | |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | Chief People Officer | 09 Sep 2026 | 2,293 | 0 | - | - | Warrant (Right to Buy) | ||
| Aquestive Therapeutics Inc | Mr. Peter Boyd | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.18 per share. | 05 May 2026 | 56,778 | 281,731 (0%) | 0% | 4.2 | 237,332 | Common Stock |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 80,000 | 368,323 (1%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 80,000 | 368,323 (1%) | 0% | 0 | - | |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | Chief People Officer | 09 Mar 2026 | 42,500 | 42,500 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Aquestive Therapeutics Inc | Mr. Peter Boyd | Chief People Officer | Sale of securities on an exchange or to another person at price $ 4.17 per share. | 09 Mar 2026 | 29,814 | 338,509 (1%) | 0% | 4.2 | 124,414 | Common Stock |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | Chief People Officer | Sale of securities on an exchange or to another person at price $ 4.17 per share. | 09 Mar 2026 | 29,814 | 338,509 (1%) | 0% | 4.2 | 124,414 | - |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2025 | 20,000 | 288,323 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | See Remarks | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 15 Oct 2025 | 10,000 | 268,323 (0%) | 0% | 7 | 70,000 | Common Stock |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | See Remarks | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 26 Sep 2025 | 10,000 | 278,323 (0%) | 0% | 6.3 | 63,000 | Common Stock |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | See Remarks | Sale of securities on an exchange or to another person at price $ 5.30 per share. | 05 Sep 2025 | 15,000 | 288,323 (0%) | 0% | 5.3 | 79,500 | Common Stock |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | See Remark | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 80,000 | 317,628 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | Chief People Officer | 07 Mar 2025 | 60,000 | 60,000 | - | - | Performance Stock Units | ||
| Aquestive Therapeutics Inc | Mr. Peter Boyd | See Remark | 07 Mar 2025 | 40,000 | 40,000 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Aquestive Therapeutics Inc | Mr. Peter Boyd | See Remark | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 7,681 | 303,323 (0%) | 0% | 2.7 | 20,355 | Common Stock |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | See Remark | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 6,624 | 311,004 (0%) | 0% | 2.7 | 17,554 | Common Stock |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | See Remark | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 8,370 | 237,628 (0%) | 0% | 4.9 | 40,846 | Common Stock |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | See Remark | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 86,250 | 245,998 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | See Remark | 07 Mar 2024 | 43,125 | 43,125 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Aquestive Therapeutics Inc | Mr. Peter Boyd | See Remark | 09 Aug 2023 | 50,000 | 50,000 | - | - | Performance Stock Units | ||
| Aquestive Therapeutics Inc | Mr. Peter Boyd | See Remark | 05 May 2023 | 50,000 | 50,000 | - | - | Performance Stock Units | ||
| Aquestive Therapeutics Inc | Mr. Peter Boyd | See Remark | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 100,000 | 159,532 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | SVP-Bus. Process & Info. Tech. | 04 Nov 2022 | 25,000 | 25,000 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Aquestive Therapeutics Inc | Mr. Peter Boyd | SVP-Bus. Process & Info. Tech. | Purchase of securities on an exchange or from another person at price $ 0.81 per share. | 14 Jun 2022 | 5,000 | 59,532 (0%) | 0% | 0.8 | 4,050 | Common Stock |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | SVP-Bus. Process & Info. Tech. | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 08 Jun 2022 | 2,293 | 54,532 (0%) | 0% | 1.0 | 2,201 | Common Stock |
| Aquestive Therapeutics Inc | Mr. Peter Boyd | SVP-Bus. Process & Info. Tech. | 08 Jun 2022 | 2,293 | 2,293 | - | - | Warrant (Right to Buy) | ||
| Aquestive Therapeutics Inc | Mr. Peter Boyd | SVP-Bus. Process & Info. Tech. | 10 Mar 2022 | 70,000 | 70,000 | - | - | Non-Qualified Stock Option (right to buy) |